| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10741-019-09777-2 |
| P698 | PubMed publication ID | 30848404 |
| P50 | author | Willemien J Kruik-Kollöffel | Q84203891 |
| P2093 | author name string | Job van der Palen | |
| Kris L L Movig | |||
| Edith M Heintjes | |||
| Gerard C M Linssen | |||
| H Joost Kruik | |||
| P2860 | cites work | Patterns of pharmacotherapy in patients hospitalised for congestive heart failure | Q28195422 |
| Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) | Q28378044 | ||
| Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study | Q34155432 | ||
| ??? | Q28267062 | ||
| Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). | Q34383304 | ||
| Guidelines for the diagnosis and treatment of chronic heart failure | Q34516865 | ||
| 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib | Q34677347 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction | Q38965377 | ||
| Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people | Q39069454 | ||
| Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. | Q40173081 | ||
| Impact of clinical characteristics and management on the prognosis of unselected heart failure patients | Q41381001 | ||
| β blockers for heart failure | Q42850771 | ||
| Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry | Q44183566 | ||
| Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms | Q44272913 | ||
| Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. | Q46184662 | ||
| Diuretic Treatment in Heart Failure | Q47707757 | ||
| Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades | Q47767547 | ||
| Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. | Q51462051 | ||
| Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. | Q52631597 | ||
| Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement. | Q53121367 | ||
| Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry | Q57628639 | ||
| The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology | Q61651523 | ||
| The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial | Q74452235 | ||
| Predictors of long-term persistence on statins in a subsidized clinical population | Q82494168 | ||
| 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society o | Q87967845 | ||
| Are Guidelines Merely Suggestions? | Q90344851 | ||
| Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry | Q90868814 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacoepidemiology | Q158230 |
| hospitalization | Q3140971 | ||
| Drug therapy | Q58071379 | ||
| P304 | page(s) | 499-510 | |
| P577 | publication date | 2019-07-01 | |
| P1433 | published in | Heart Failure Reviews | Q2167497 |
| P1476 | title | Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015 | |
| P478 | volume | 24 |
| Q103032639 | Impact of sex differences in co-morbidities and medication adherence on outcome in 25 776 heart failure patients | cites work | P2860 |
Search more.